Coronary Syndrome
📧 Sign up to get email alerts when something new happens for Coronary Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-06-10Clinical Trial Update: Low-dose Interleukin-2 for the Reduction of Vascular Inflammation in Acute Coronary Syndromes - IVORY [Phase 2]
Phase 2 trial evaluating whether low-dose interleukin-2 reduces vascular inflammation in acute coronary syndromes; the study has completed.
-
CLINICAL_TRIALS research · 2024-06-10Clinical Trial Update: Low-Dose IL-2 For The Reduction Of Vascular Inflammation In ACS -Clinical Outcomes & Follow-up Study
A clinical trial evaluating low-dose interleukin-2 to reduce vascular inflammation in patients with acute coronary syndrome, currently recru…
-
CLINICAL_TRIALS research · 2024-06-04Clinical Trial Update: Telemonitoring System for Improving Continuity of Care in Patients With Chronic Coronary Syndrome (TELSINCORC) [NA]
A clinical trial evaluating a telemonitoring system intended to improve continuity of care for patients with Chronic Coronary Syndrome is cu…
-
FDA approval · 2024-05-29FDA Approved: PRASUGREL — Supplemental Application (Accord Healthcare Inc.)
The FDA approved a supplemental application for prasugrel from Accord Healthcare Inc., enabling a generic prasugrel product to be marketed. …
-
FDA approval · 2024-05-29FDA Approved: PRASUGREL — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approves Mylan’s supplemental application for prasugrel, enabling a generic version under ANDA205927.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-05-29Clinical Trial Update: Florbetaben for Imaging of Vascular Amyloid
A clinical trial is recruiting to evaluate Florbetaben for imaging vascular amyloid, sponsored by the Ottawa Heart Institute Research Corpor…
-
CLINICAL_TRIALS trial_result · 2024-05-28Clinical Trial Update: Switching From Cardiac Troponin I to T
University of Edinburgh completed a clinical trial evaluating switching from cardiac troponin I to troponin T as a biomarker. The study enco…
-
CLINICAL_TRIALS research · 2024-05-22Clinical Trial Update: Preventive Drug-coated Balloon Angioplasty in Vulnerable Atherosclerotic Plaque (RESTORE Trial) [NA]
Clinical trial RESTORE is evaluating preventive drug-coated balloon angioplasty to treat vulnerable atherosclerotic plaque in patients with …
-
CLINICAL_TRIALS research · 2024-05-22Clinical Trial Update: 3rd Generation Resorbable Magnesium Scaffolds vs Biodegradable Polymer Stents in NSTE/ACS [Phase 4]
A Phase 4 clinical trial compares a third-generation resorbable magnesium scaffold with a biodegradable polymer stent in patients with acute…
-
CLINICAL_TRIALS research · 2024-05-21Clinical Trial Update: High-Sensitivity Cardiac Troponin On Presentation to Rule Out Myocardial Infarction [NA]
A completed trial evaluating whether high-sensitivity cardiac troponin measured at presentation can rule out myocardial infarction in suspec…
-
CLINICAL_TRIALS research · 2024-05-20Clinical Trial Update: Continuity of Care Between Primary Care Cardiology and Specialty Services for Patients With Chronic Ischemic Heart Disease [Phase 4]
This entry notes a Phase 4 clinical trial evaluating continuity of care between primary care cardiology and specialty services for patients …
-
CLINICAL_TRIALS trial_result · 2024-05-16Clinical Trial Update: Remote-delivered MBCT for SCAD Survivors [Phase 1]
Phase 1 trial evaluating remote-delivered Mindfulness-Based Cognitive Therapy for survivors of spontaneous coronary artery dissection, addre…
-
CLINICAL_TRIALS research · 2024-05-16Clinical Trial Update: Clinical Effects of Intra-aortic Balloon Support in Early Acute Coronary Syndrome and Non-Acute Coronary Syndrome Related Cardiogenic Shock [NA]
This clinical trial from Erasmus Medical Center investigates the clinical effects of intra-aortic balloon pump support in patients with card…
-
CLINICAL_TRIALS research · 2024-05-13Clinical Trial Update: Biomarkers in Acute Cardiac Care
A clinical trial at Universitätsklinikum Hamburg-Eppendorf is currently recruiting to evaluate biomarkers in the management of acute coronar…
-
CLINICAL_TRIALS trial_result · 2024-05-13Clinical Trial Update: Pragmatic Collaborative Care for Cardiac Inpatients With Depression or Anxiety [NA]
This study has completed a pragmatic trial evaluating collaborative care for depression or anxiety in cardiac inpatients. It targets patient…
-
CLINICAL_TRIALS research · 2024-05-10Clinical Trial Update: Impact Of Subclinical Hypothyroidism On Short-Term Outcomes In Patients With Acute Coronary Syndrome In Sohag University Hospitals
This clinical trial from Sohag University Hospitals is evaluating whether subclinical hypothyroidism affects short-term outcomes in patients…
-
FDA approval · 2024-05-09FDA Approved: EPTIFIBATIDE — Original Application (Meitheal Pharmaceuticals Inc.)
FDA approved Meitheal Pharmaceuticals' original application (ANDA) for a generic version of eptifibatide (Integrilin). The approval permits …
-
CLINICAL_TRIALS research · 2024-05-08Clinical Trial Update: Clinical Cohort Study - INTERCATH
Clinical trial update for the INTERCATH cohort study sponsored by the University of Hamburg-Eppendorf, focusing on coronary artery disease-r…
-
CLINICAL_TRIALS research · 2024-05-01Clinical Trial Update: The Pre-hospital Evaluation of Sensitive Troponin (PRESTO) Study
The PRESTO trial evaluates pre-hospital troponin testing for patients with chest pain and suspected acute coronary syndrome; the study is cu…
-
CLINICAL_TRIALS trial_result · 2024-04-26Clinical Trial Update: Safety and Effectiveness of the Orsiro Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions
Clinical trial update reporting safety and effectiveness results for the Orsiro sirolimus-eluting coronary stent system in patients with cor…
-
CLINICAL_TRIALS research · 2024-04-25Clinical Trial Update: AI Algorithms in Prediction of ACS Based on Leukocyte Properties
This clinical trial entry shows recruiting status for a study evaluating AI algorithms that predict acute coronary syndrome using leukocyte …
-
CLINICAL_TRIALS trial_result · 2024-04-22Clinical Trial Update: A sTudy of Low Dose vs Standard Dose of tIcaGrelor on Platelet Function After intErvention for Acute Coronary syndRome in Diabetes Mellitus Patients [Phase 4]
Phase 4 trial comparing low dose versus standard dose ticagrelor on platelet function in acute coronary syndrome patients with diabetes afte…
-
FDA approval · 2024-04-17FDA Approved: PRASUGREL — Supplemental Application (Apotex Corp.)
The FDA approved a supplemental application for prasugrel submitted by Apotex Corp.
-
CLINICAL_TRIALS trial_result · 2024-04-17Clinical Trial Update: Yangxinshi Tablet Intervention for Exercise Capacity in Patients With Chronic Coronary Syndrome [Phase 4]
Phase 4 clinical trial update evaluating Yangxinshi Tablet for exercise capacity in patients with chronic coronary syndrome.
-
CLINICAL_TRIALS trial_result · 2024-04-04Clinical Trial Update: The Reducing Exercise Sensitivity With Exposure Training (RESET) Study [NA]
A terminated clinical trial study update for the RESET study investigating exposure training to reduce exercise sensitivity in patients with…